Genomic information on Stenotrophomonas maltophilia ST264 isolated from a cystic fibrosis pediatric patient in Brazil.
Fabrina Seger BragaAna Paula D'Allincourt Carvalho AssefRobson Souza LeãoRodolpho Mattos AlbanoElizabeth Andrade MarquesPublished in: Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] (2019)
Stenotrophomonas maltophilia is one of the Gram-negative bacilli most frequently found in the airways of cystic fibrosis patients. This opportunistic pathogen is intrinsically multidrug-resistant, and therefore, its treatment presents a challenge. The genetic characterization of S. maltophilia is largely unknown, especially from those strains that colonize/infect the airways of cystic fibrosis patients. This work reports the draft genome sequences of three S. maltophilia isolates recovered from the sputum of a cystic fibrosis pediatric patient in Southeast Brazil. Several resistance- and virulence-related genes were detected. Furthermore, one intact phage and one incomplete prophage region were also identified in all strains. Multilocus sequence typing showed that all strains belonged to a new sequence type (ST264). Interestingly, all S. maltophilia strains were genetically identical, showing persistence for at least 16 months. To our knowledge, this is the first report of S. maltophilia draft genome sequences obtained from a cystic fibrosis pediatric patient in Brazil.
Keyphrases
- cystic fibrosis
- pseudomonas aeruginosa
- gram negative
- multidrug resistant
- escherichia coli
- lung function
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- acinetobacter baumannii
- peritoneal dialysis
- prognostic factors
- healthcare
- drug resistant
- gene expression
- biofilm formation
- dna methylation
- social media
- genome wide
- antimicrobial resistance
- air pollution
- chronic obstructive pulmonary disease
- replacement therapy